Conclusions: The Young Cancer Portal is unique throughout Germany and offers a new way for expert-patient-communication with high acceptance by long-term survivors. The portals basic structure is appropriate for a enables the modular addition of topics. Modules for long-term effects and integrative oncology will be established.
Background: Health-related quality of life (HRQoL) measurement among adolescents and young adults (AYA) with cancer is instrumental to identify areas of need and to organize age-specific psychosocial care. Health care professionals (HCP) are not always aware of what matters most to patients. The aims of the current study were to determine top 10 HRQoL priorities relevant to AYA cancer patients and HCP and to determine discrepancies between items prioritized by AYA and HCP. Methods: Patients aged 18 to 35 years at time of cancer diagnosis and who had been seen by one of the members of the multidisciplinary AYA team of Radboud university medical center in the Netherlands, and Dutch HCP involved in AYA oncology were invited to complete the Quality of Life for Cancer Survivors questionnaire. Results: 83 AYA cancer patients and 34 HCP completed the questionnaire. Patients scored significantly lower on negatively formulated HRQoL issues (e.g. fatigue, coping difficulties, feeling isolated) and significantly higher on positive formulated issues (e.g. support from others, overall physical health, happiness). Most important HRQoL items scored by AYA patients were: perceived support from others, distress about initial cancer diagnosis, distress for family, overall quality of life and happiness. HCP perceived distress about initial cancer diagnosis, distress for family, cancer treatment distress, interference of illness with employment/study and fatigue as most important HRQoL items. Patients and HCP had a congruence on 5 out of 10 HRQoL items where distress about initial cancer diagnosis, distress for family and cancer treatment distress were the main overlapping issues. There was a incongruence on fatigue, sexuality and concerns about fertility as these items only appeared in the top 10 HRQoL items rated by HCP and not in the top 10 for AYA patients. Conclusions: AYA cancer patients perceived most HRQoL items as less problematic in comparison to HCP, in particular regarding physical symptoms, psychological and social HRQoL issues. The discrepancy between patients and HCP illustrates the importance of patient participation, i.e. involving patients in organizing and prioritizing their own (psychosocial) care. Legal entity responsible for the study: Radboud University Medical Center. Funding: Has not received any funding. Disclosure: All authors have declared no conflicts of interest.
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Background: Social media is increasingly used by patients for cancer information and psychosocial support. Certain information/features may be more desired in a new hospital-based social media cancer resource; these may vary between adolescent-young adult (AYA; age <40) and non-AYA (age 40þ). Methods: Using age specific sampling, cancer patients across all disease sites completed a cross-sectional survey of demographics, health status, and social media/online resource use for cancer education. Clinical information was abstracted.
Results: Of 127 AYA cancer patients and 193 non-AYA (older adult) patients, 100% (AYA) and 92% (non-AYA) stated they use the internet (p < 0.001); 95% AYA and 72% non-AYA used social media (p < 0.001). When asked about attitudes towards social media, 64% AYA and 50% non-AYA believed they could judge social media information quality; 18% AYA and 18% non-AYA recommended use of current social media resources. When asked what types of features they would want in an online resource for their cancer care, both AYA and non-AYA most frequently reported wanting to view their own personal health records (82% AYA/63% non-AYA), followed by an online library of cancer resources (73% AYA/ 56% non-AYA), ability to communicate with healthcare professionals (73% AYA/55% non-AYA), and appointment reminders (72% AYA/58% non-AYA). The most frequently desired information for both groups were treatment options (61% AYA/56% non-AYA), causes/risk factors/symptoms (65% AYA/56% non-AYA), and prognosis/outcomes (52% AYA/46% non-AYA). The largest difference in information preference between the two age groups were in wellness programs (62% AYA/39% non-AYA) and work return (42% AYA/ 20% non-AYA) (p < 0.001).
Conclusions: There is significant agreement between AYA and non-AYA patients in the most desired information and features they want in a social media resource, though AYA patients wanted a greater number of features. Patients' desired information suggested a patient preference for more autonomy and insight into their disease, regardless of age. There is a lack of satisfaction with current social media resources. A single set of informational tools can therefore be developed for all adults. Background: Hypothyroidism was a known and common side effect from multikinase inhibitors notably in sunitinib, pazopanib and sorafenib. The goal of this study was to explore risk factors in developing hypothyroid and whether the occurrence of this endocrine adverse event (AE) leading to better survival outcomes. Methods: Seventy-one renal cell carcinoma (RCC) patients and 136 hepatocellular carcinoma (HCC) patients were retrospectively analyzed. Data relating to the treatment course and development of hypothyroid were collected, extracted and presented in separate cohort. Results: The incidence of hypothyroidism was 47.8% in RCC patients treated with either sunitinib or pazopanib. For HCC patients whom received sorafenib, the incidence of hypothyroidism was 31.8%. We found no factor significantly associated with hypothyroidism in RCC patients. HCC patients whom had duration of treatment of less than 3 months tend to develop hypothyroidism. There was no significant association between the development of hypothyroid and PFS or OS in RCC patients. In HCC group, euthyroid patients had statistically significant longer mPFS [7.6 vs. 2 Center for Biostatistics, The Ohio State University James Cancer Hospital, Columbus, OH, USA Background: Immune checkpoint inhibitors (ICI) have transformed oncology practice, however serious immune-related adverse events (irAE) occur and are poorly understood. A correlation between irAE and clinical benefit has been suggested in melanoma, non-small cell lung cancer (NSCLC), and renal cell carcinoma (RCC). The incidence of irAEs has been described in clinical trials but risks factors remain undefined. This study reports the incidence and risks factors of irAE in patients (pts) with multiple cancers treated with any ICI, as well as overall survival. Methods: A retrospective study of pts with any malignancy treated with ICI (alone or in combination) between January 2010 and June 2017 was carried out at The Ohio State University. Grade > ¼ 2 irAEs were abstracted based on the treating physician diagnosis. Overall survival (OS) was calculated from the date of initiation of ICI to death from any cause or date of last follow-up. The associations between irAE incidence 
